A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
一项针对抗白细胞介素 6 单克隆抗体 siltuximab 治疗复发或难治性多发性骨髓瘤患者的 2 期多中心研究
期刊:British Journal of Haematology
影响因子:5.1
doi:10.1111/bjh.12266
Peter M Voorhees, Robert F Manges, Pieter Sonneveld, Sundar Jagannath, George Somlo, Amrita Krishnan, Suzanne Lentzsch, Richard C Frank, Sonja Zweegman, Pierre W Wijermans, Robert Z Orlowski, Britte Kranenburg, Brett Hall, Tineke Casneuf, Xiang Qin, Helgi van de Velde, Hong Xie, Sheeba K Thomas